Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Nagio Takigawa

Department of Respiratory Medicine

Okayama University Hospital

Kitaku

Okayama

Japan

[email]@md.okayama-u.ac.jp

Name/email consistency: high

[Claim this account]

Affiliations

Department of Respiratory Medicine, Okayama University Hospital, Kitaku, Okayama, Japan. 2006 - 2011
Department of Internal Medicine, National Hospital Organization, Minami-Okayama Medical Center, 4066 Hayashima, Japan. 2007
Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Japan. 2006

References

Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007. Takigawa, N., Kiura, K., Segawa, Y., Hotta, K., Tamaoki, A., Tokuda, Y., Nagata, T., Watanabe, K., Gemba, K., Moritaka, T., Horita, N., Takeda, H., Okimoto, N., Takemoto, M., Matsuo, K., Shinkai, T., Tabata, M., Ueoka, H., Kanazawa, S., Tanimoto, M. J. Thorac. Oncol (2011) [Pubmed]
Comprehensive pulmonary rehabilitation according to severity of COPD. Takigawa, N., Tada, A., Soda, R., Takahashi, S., Kawata, N., Shibayama, T., Matsumoto, H., Hamada, N., Hirano, A., Kimura, G., Okada, C., Endo, S., Yamashita, M., Date, H., Takahashi, K. Respir. Med (2007) [Pubmed]
Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Takigawa, N., Tada, A., Soda, R., Date, H., Yamashita, M., Endo, S., Takahashi, S., Kawata, N., Shibayama, T., Hamada, N., Sakaguchi, M., Hirano, A., Kimura, G., Okada, C., Takahashi, K. Respir. Med (2007) [Pubmed]
Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells. Takigawa, N., Takeyama, M., Kozuki, T., Shibayama, T., Hisamoto, A., Kiura, K., Tada, A., Hotta, K., Umemura, S., Ohashi, K., Fujiwara, Y., Takata, S., Ichihara, E., Osawa, M., Tabata, M., Tanimoto, M., Takahashi, K. Oncol. Rep. (2007) [Pubmed]
The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells. Takigawa, N., Takeyama, M., Shibayama, T., Tada, A., Kawata, N., Okada, C., Aoe, K., Kozuki, T., Hotta, K., Tabata, M., Kiura, K., Ueoka, H., Tanimoto, M., Takahashi, K. Oncol. Rep. (2006) [Pubmed]
Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer. Takigawa, N., Kiura, K., Segawa, Y., Watanabe, Y., Kamei, H., Moritaka, T., Shibayama, T., Ueoka, H., Gemba, K., Yonei, T., Tabata, M., Shinkai, T., Hiraki, S., Takemoto, M., Kanazawa, S., Matsuo, K., Tanimoto, M. Br. J. Cancer (2006) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.